The role of genetic and other biomarkers in NSCLC prognosis

The role of genetic and other biomarkers in NSCLC prognosis

Bibliographic Details
Main Authors:	Schveigert Diana, Cicenas Saulius, Bublevic Jaroslav, Askinis Renatas, Sapoka Virginijus, Didziapetriene Janina
Format:	Article
Language:	English
Published:	De Gruyter 2014-06-01
Series:	Open Medicine
Subjects:	Non-small cell lung cancer Biomarkers Prognosis
Online Access:	http://www.degruyter.com/view/j/med.2014.9.issue-3/s11536-013-0290-2/s11536-013-0290-2.xml?format=INT

Similar Items

Cell-free DNA in non-small cell lung cancer
by: Vaida Gedvilaitė, et al.
Published: (2017-07-01)

Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC
by: Julija Simiene, et al.
Published: (2023-09-01)

Surgery for lung cancer as the second primary malignancy
by: Arnoldas Krasauskas, et al.
Published: (2013-01-01)

Vaizdo torakoskopijos reikšmė diagnozuojant ir gydant plaučių ir krūtinės ligas
by: Renatas Aškinis, et al.
Published: (2007-01-01)

Vaizdo torakoskopijos galimybės gydant įvairios etiologijos pleuritą
by: Renatas Aškinis, et al.
Published: (2007-01-01)

How should a clinician interpret results of randomized controlled trials?
by: Virginijus ŠAPOKA, et al.
Published: (2010-01-01)

CCKAR is a biomarker for prognosis and asynchronous brain metastasis of non-small cell lung cancer
by: Nan Liang, et al.
Published: (2023-01-01)

TIMP1 is an early biomarker for detection and prognosis of lung cancer
by: Ezequiel Dantas, et al.
Published: (2023-10-01)

Association of seven antibody levels in lung cancer with chemotherapy effect and prognosis in patients with NSCLC
Published: (2024-10-01)

HEG1 as a novel potential biomarker for the prognosis of lung adenocarcinoma
by: Xin Zou, et al.
Published: (2023-02-01)

Significance of blood serum catalase activity and malondialdehyde level for survival prognosis of ovarian cancer patients
by: Janina Didžiapetrienė, et al.
Published: (2014-01-01)

IGF2R Expression is Associated with the Chemotherapy Response and Prognosis of Patients with Advanced NSCLC
by: Zhennan Tian, et al.
Published: (2014-10-01)

The inflammatory burden index is a superior systemic inflammation biomarker for the prognosis of non‐small cell lung cancer
by: Hailun Xie, et al.
Published: (2023-04-01)

Notch 3 Protein, not its Gene Polymorphism, is Associated with the Chemotherapy Response and Prognosis of Advanced NSCLC Patients
by: Chunlei Shi, et al.
Published: (2014-08-01)

Small Cell Size Circulating Aneuploid Cells as a Biomarker of Prognosis in Resectable Non-Small Cell Lung Cancer
by: Yang Hong, et al.
Published: (2021-03-01)

Ankstyvų stadijų nesmulkialąstelio plaučio vėžio chirurginio gydymo rezultatai
by: Renatas Aškinis, et al.
Published: (2016-09-01)

Klajoklio nervo krūtininės dalies neurilemoma: klinikinis atvejis
by: Renatas Aškinis, et al.
Published: (2014-01-01)

Klajoklio nervo krūtininės dalies neurilemoma: klinikinis atvejis
by: Renatas Aškinis, et al.
Published: (2012-01-01)

Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis
by: Yingji Chen, et al.
Published: (2021-04-01)

CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma
by: Jianlong Tan, et al.
Published: (2022-09-01)

Methods of main bronchus stump closure and incidence of bronchopleural fistula after pneumonectomies for lung cancer (a retrospective single center review)
by: Saulius Cicėnas, et al.
Published: (2014-02-01)

Outcomes of Patients With Advanced NSCLC From the Intergroupe Francophone de Cancérologie Thoracique Biomarkers France Study by KRAS Mutation Subtypes
by: Anne-Marie Ruppert, MD, PhD, et al.
Published: (2020-09-01)

Exploring FNDC4 as a biomarker for prognosis and immunotherapy response in lung adenocarcinoma
by: Shengshan Xu, et al.
Published: (2025-03-01)

Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non‐small cell lung cancer
by: Yujiao Xie, et al.
Published: (2018-05-01)

A non-linear association between blood tumor mutation burden and prognosis in NSCLC patients receiving atezolizumab
by: Wei Nie, et al.
Published: (2020-01-01)

Genomic Landscape of NSCLC in the Republic of Ireland
by: Rachel J. Keogh, MB BCH BAO, et al.
Published: (2024-02-01)

Circulating MicroRNAs in Blood and Other Body Fluids as Biomarkers for Diagnosis, Prognosis, and Therapy Response in Lung Cancer
by: Luis Vicente Gayosso-Gómez, et al.
Published: (2021-03-01)

Advances in biomarkers for immunotherapy in small-cell lung cancer
by: Hui Li, et al.
Published: (2024-12-01)

Based on Cardiopulmonary Exercise Testing to Construct and Validate Nomogram of Long‐Term Prognosis Within 12 Months for NSCLC
by: Xinyu Wang, et al.
Published: (2024-08-01)

Mediastinoskopijos svarba vertinant plaučių vėžio išplitimą į tarpuplautį
by: Saulius Cicėnas, et al.
Published: (2007-01-01)

Vietiškai išplitusio plaučių vėžio (T4) ir tarpuplaučio piktybinių navikų chirurginis gydymas
by: Saulius Cicėnas, et al.
Published: (2007-01-01)

Chirurginis pleuros piktybinės mezoteliomos gydymas
by: Saulius Cicėnas, et al.
Published: (2007-01-01)

Stemplės vėžio gydymo rezultatai Nacionaliniame vėžio institute 2008–2017 metais
by: Sigitas Zaremba, et al.
Published: (2019-07-01)

Susiaurėjusio stambiųjų bronchų ir trachėjos spindžio gydymas
by: Renatas Aškinis, et al.
Published: (2010-01-01)

Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial
by: Raquel Laza‐Briviesca, et al.
Published: (2021-07-01)

circIARS: a potential plasma biomarker for diagnosing non-small cell lung cancer
by: Zhang Qi, et al.
Published: (2024-04-01)

SLC6A8 is a Potential Biomarker for Poor Prognosis in Lung Adenocarcinoma
by: Yongfei Fan, et al.
Published: (2022-05-01)

Update on adjuvant therapy in completely resected NSCLC patients
by: Jeong Uk Lim, et al.
Published: (2022-02-01)

Circulating Biomarkers for Prediction of Immunotherapy Response in NSCLC
by: Kah Yee Goh, et al.
Published: (2023-02-01)

The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysis
by: Chuchu Shao, et al.
Published: (2019-11-01)